Effexor and Neutrophil count abnormal - a phase IV clinical study of FDA data


Neutrophil count abnormal is found among people who take Effexor, especially for people who are male, 40-49 old.

The phase IV clinical study analyzes which people take Effexor and have Neutrophil count abnormal. It is created by eHealthMe based on reports of 88,368 people who have side effects when taking Effexor from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 01, 2023

88,368 people reported to have side effects when taking Effexor.
Among them, 9 people (0.01%) have Neutrophil count abnormal.

What is Effexor?

Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 95,375 Effexor users for its effectiveness, alternative drugs and more.

What is Neutrophil count abnormal?

Neutrophil count abnormal (abnormal number of neutrophil a type of blood cell) is found to be associated with 754 drugs and 357 conditions by eHealthMe.

Number of Effexor and Neutrophil count abnormal reports submitted per year:

Could Effexor cause Neutrophil count abnormal?

Gender of people who have Neutrophil count abnormal when taking Effexor *:

  • female: 44.44 %
  • male: 55.56 %

Age of people who have Neutrophil count abnormal when taking Effexor *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 25.0 %
  • 20-29: 0.0 %
  • 30-39: 25.0 %
  • 40-49: 37.5 %
  • 50-59: 0.0 %
  • 60+: 12.5 %

Common drugs people take besides Effexor *:

  1. Zyprexa: 2 people, 22.22%
  2. Vioxx: 2 people, 22.22%
  3. Humalog: 2 people, 22.22%
  4. Flagyl: 2 people, 22.22%
  5. Seroquel: 2 people, 22.22%
  6. Celexa: 2 people, 22.22%
  7. Risperidone: 2 people, 22.22%
  8. Xanax: 2 people, 22.22%
  9. Advil: 2 people, 22.22%
  10. Ambien: 1 person, 11.11%

Common side effects people have besides Neutrophil count abnormal *:

  1. Fatigue (feeling of tiredness): 5 people, 55.56%
  2. Haemoglobin Decreased: 4 people, 44.44%
  3. Weakness: 3 people, 33.33%
  4. Urination - Painful: 3 people, 33.33%
  5. Pancreatic Atrophy: 2 people, 22.22%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 22.22%
  7. Drowsiness: 2 people, 22.22%
  8. Pseudocyst (pathological collection of fluid): 2 people, 22.22%
  9. Diabetes: 2 people, 22.22%
  10. Headache (pain in head): 2 people, 22.22%

Common conditions people have *:

  1. Schizoaffective Disorder (a mental disorder characterized by disordered thought): 2 people, 22.22%
  2. Breast Cancer Metastatic: 2 people, 22.22%
  3. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 11.11%
  4. Psoriasis (immune-mediated disease that affects the skin): 1 person, 11.11%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 11.11%
  6. Headache (pain in head): 1 person, 11.11%
  7. Gait Disturbance: 1 person, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Effexor and have Neutrophil count abnormal?

Check whether Neutrophil count abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Neutrophil count abnormal and when was it recovered:

Expand to all the drugs that have ingredients of venlafaxine hydrochloride:

Alternative drugs to, pros and cons of Effexor:

Common Effexor side effects:

Browse all side effects of Effexor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Neutrophil count abnormal treatments and more:

COVID vaccines that are related to Neutrophil count abnormal:

Common drugs associated with Neutrophil count abnormal:

All the drugs that are associated with Neutrophil count abnormal:

Common conditions associated with Neutrophil count abnormal:

All the conditions that are associated with Neutrophil count abnormal:

How the study uses the data?

The study uses data from the FDA. It is based on venlafaxine hydrochloride (the active ingredients of Effexor) and Effexor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: